- Turkish researchers at Üsküdar University have published in vitro laboratory studies of transgenic CAR-T cell therapy for Acute Lymphoblastic Leukemia in the SCI-indexed Vaccines journal. - Akdeniz University has become the eighth facility worldwide to adopt CAR-T cell therapy, officially launching clinical trials with blood samples collected from nine selected patients. - The domestically produced CAR-T therapy aims to engineer patients' immune cells to target cancer cells, with 678 patients already applying for treatment and comprehensive treatment scheduled to begin in June.

Mar 2, 2026

返回机构列表

Akdeniz Üniversitesi

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（291）

Posture Protection Program for Musculoskeletal Disorders and Ergonomic Risk in Hospital Cleaning Staff

Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients

Investigation of Muscle Activity With sEMG, Surface Topography and Radiographic Changes of Paraspinal Muscles in Individuals With Adolescent Idiopathic Scoliosis.

Human Caring Theory-Based Yoga and Anxiety

Effect of Progressive Muscle Relaxation on Parental Anxiety

Elastic Band Exercises With Blood Flow Restriction Technique in Tennis Players

Three-Dimensional Scoliosis Exercises and Diaphragmatic Manual Techniques in Adolescents With Idiopathic Scoliosis

Virtual Reality Exergaming During Work Breaks in Office Employees

药物批准

资讯

Turkish Universities Launch Clinical Trials for Domestically Produced CAR-T Cell Therapy Against Blood Cancers